Pharming (PHAR) Net Cash Flow (2019 - 2025)
Pharming (PHAR) posted Net Cash Flow of $11.7 million for Q4 2025, up 125.44% on a QoQ basis from -$46.0 million in Q4 2024, and up 125.44% year-over-year from $5.2 million in Q4 2024.
Pharming (PHAR) Net Cash Flow (2019 - 2025) Analysis & Trends
Pharming's Net Cash Flow history runs 7 years deep, the most recent figure standing at $11.7 million for Q4 2025.
- Quarterly Net Cash Flow rose 125.44% year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 135.1% YoY) and the FY2025 annual result came in at $82.5 million, up 1896.8% from the prior year.
- Net Cash Flow was $11.7 million for Q4 2025 at Pharming, up from -$46.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $12.7 million in Q3 2024 and bottomed at -$147.7 million in Q4 2023.
- A 5-year average of -$32.1 million and a median of -$3.7 million in 2021 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 320.48% in 2022, while the deepest fall reached 24027.9% in 2022.
- Pharming's Net Cash Flow stood at -$11003.9 in 2021, then tumbled by 24027.9% to -$2.7 million in 2022, then slumped by 5464.18% to -$147.7 million in 2023, then jumped by 68.86% to -$46.0 million in 2024, then surged by 125.44% to $11.7 million in 2025.
- Business Quant data shows PHAR's Net Cash Flow at $11.7 million in Q4 2025, -$46.0 million in Q4 2024, and $12.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.70 Mn |
| Dec 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | -46.00 Mn |
| Dec 31, 2024 | -46.00 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Dec 31, 2023 | -147.73 Mn |
| Dec 31, 2023 | -147.73 Mn |
| Sep 30, 2023 | -49.46 Mn |
| Sep 30, 2023 | -49.46 Mn |
| Jun 30, 2023 | -104.92 Mn |
| Jun 30, 2023 | -104.92 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Sep 30, 2022 | 10.40 Mn |
| Sep 30, 2022 | 10.40 Mn |
| Dec 31, 2021 | -11,003.86 |
| Dec 31, 2021 | -11,003.86 |
| Sep 30, 2021 | -4.72 Mn |
| Sep 30, 2021 | -4.72 Mn |